Industry Symposia (Lunch)

Thursday, October 18

Lunch Symposium

12:00 – 13:00 AstraZeneca (ballroom I)

De Novo Oligometastatic Hormone Sensitive Prostate Cancer – Do Patients Benefit From Local Ablative Therapy With ADT?

image

Moderator:

Lincoln Tan

12:00-12:10

Are We Undertreating Oligometastatic Disease?”

Lincoln Tan

How Should We Treat Oligometastatic Prostate Cancer in 2018?

12:10-12:20

Systemic Therapy Alone Is The Truth, Anything Else Is Wishful Thinking!

Ravindran Kanesvaran

12:20-12:30

Cytoreductive And Metastasis Directed Radiotherapy – Chance For Cure?

Jeffrey Tuan

12:30-12:40

Role Of Robotic Surgery In Oligometastatic Disease

Rha Koon Ho

12:40-12:50

Case Study Discussion

All

12:50-13:00

Q&A

Lunch Symposium

12:00- 13:00 Sanofi (ballroom II)

image

VTE Risk In OBGYN Surgery

Moderator:

Jeffrey Low

Speaker:

Tan Thiam Chye

Friday, October 19

Lunch Symposium

12:00 – 13:00 AstraZeneca (ballroom II)

Cancer Genetics In Ovarian Cancer: Test All, Test Early

image

Moderator:

Joseph Ng

12:00-12:05

Opening

Joseph Ng

12:05-12:25

Clinical Genetics For Cancers: Where Do We Stand Now?

Tan Min Han

12:25-12:45

Genetic Testing For Ovarian Cancer: Sooner The Better

Tay Eng Hseon

12:45-13:00

Q&A With Discussion